PDT Partners’s Reata Pharmaceuticals, Inc. Class A Common Stock RETA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
Sell
2023
Q2
$490K Sell
2023
Q1
$3.92M Buy
2022
Q4
$1.64M Sell
2022
Q3
$1.46M Sell
2022
Q2
$1.92M Buy
2022
Q1
$339K Buy